Min Kyoung Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Min Kyoung Kim has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Hyun Kang
Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea
12 shared publications - Geun Joo Choi
Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea
4 shared publications - Yong Hun Jung
Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea
3 shared publications - Hwa Yong Shin
Department of Anesthesiology and Pain Medicine, College of Medicine, Chung-Ang University, Seoul, Korea
2 shared publications - Jiwon Han
Department of Anesthesiology and Pain Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea
2 shared publications - Oh Haeng Lee
Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 21  (4) , 444-454
Oliceridine for acute pain management: pharmacology, clinical efficacy, safety, and future perspectives: a narrative review
Opioids are a cornerstone in the management of moderate-to-severe acute pain; however, their clinical utility is limited by well-recognized challenges, including respiratory depression, gastrointestinal (GI) dysfunction, and the potential for misuse and abuse. Oliceridine is a novel μ-opioid receptor agonist with G-protein-biased signaling and reduced β-arrestin recruitment. It exhibits potent analgesic effects while potentially reducing opioid-related adverse events. In preclinical investigations, oliceridine was associated with lower rates of GI dysfunction and respiratory depression than morphine. In the phase III clinical trials APOLLO-1 and APOLLO-2, certain oliceridine regimens produced rapid and effective analgesia comparable to that of morphine, with lower incidences of nausea, vomiting, and respiratory events. However, current evidence has not demonstrated a clinically meaningful overall advantage compared to conventional opioids. In addition, a clinically meaningful reduction in abuse liability relative to conventional opioids has not been established, underscoring the complexity of opioid reward mechanisms. This narrative review examines the pharmacological properties, clinical efficacy, safety profile, and ongoing controversies surrounding oliceridine and evaluates its potential role in perioperative pain management.
- 31 October 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 21  (4) , 444-454
Open AccessOliceridine for acute pain management: pharmacology, clinical efficacy, safety, and future perspectives: a narrative review
Opioids are a cornerstone in the management of moderate-to-severe acute pain; however, their clinical utility is limited by well-recognized challenges, including respiratory depression, gastrointestinal (GI) dysfunction, and the potential for misuse and abuse. Oliceridine is a novel μ-opioid receptor agonist with G-protein-biased signaling and reduced β-arrestin recruitment. It exhibits potent analgesic effects while potentially reducing opioid-related adverse events. In preclinical investigations, oliceridine was associated with lower rates of GI dysfunction and respiratory depression than morphine. In the phase III clinical trials APOLLO-1 and APOLLO-2, certain oliceridine regimens produced rapid and effective analgesia comparable to that of morphine, with lower incidences of nausea, vomiting, and respiratory events. However, current evidence has not demonstrated a clinically meaningful overall advantage compared to conventional opioids. In addition, a clinically meaningful reduction in abuse liability relative to conventional opioids has not been established, underscoring the complexity of opioid reward mechanisms. This narrative review examines the pharmacological properties, clinical efficacy, safety profile, and ongoing controversies surrounding oliceridine and evaluates its potential role in perioperative pain management.
- Open Access
- 21 July 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 21  (3) , 273-274
From visibility to influence
- 21 July 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 21  (3) , 273-274
Open AccessFrom visibility to influence
- Open Access
- 10 April 2026
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 69  (4) , 294-302
Future directions in anesthesia: expanding the role of anesthetic drugs in sedation, analgesia, and recovery
Purpose: Advances in surgical techniques, evolving patient demographics, and the expansion of perioperative care have fundamentally reshaped the objectives of modern anesthesia. Beyond maintaining intraoperative unconsciousness and physiological stability, anesthesia is now increasingly expected to influence postoperative recovery and long-term outcomes. This review examines how recent drug-centered innovations are transforming approaches to anesthesia, analgesia, and postoperative recovery and discusses their implications for the future direction of anesthetic practice.Current concepts: Modern anesthesia is delivered within a highly standardized, technology-driven environment that provides a high level of intraoperative safety. Nevertheless, substantial variability persists in postoperative recovery, neurocognitive outcomes, and complication rates, even among patients undergoing similar surgical procedures. Increasing evidence suggests that these differences are closely associated with the pharmacokinetic and pharmacodynamic properties of anesthetic agents. Accordingly, recent advances have emphasized reversibility, predictability, minimization of residual effects, and recovery-oriented pharmacology. Anesthetic agents with predictable recovery profiles, opioid-sparing multimodal analgesic strategies, and rapid neuromuscular blockade reversal exemplify this transition toward recovery-focused anesthesia management.Discussion and conclusion: Anesthetic strategies are evolving from depth-centered control toward the intentional design of recovery trajectories. Pain management is being restructured to reduce opioid-related adverse effects while promoting functional recovery through multimodal, non-opioid-based approaches. Concurrently, the emergence of reversibility as a core safety principle has reshaped anesthetic decision-making. The selection of anesthetic agents represents a central determinant of postoperative recovery, complications, and patient-centered outcomes. Anesthesia should no longer be viewed solely as a transient intraoperative intervention but rather as a deliberately designed, prognostically influential intervention grounded in strategic, evidence-based pharmacologic decision-making.
- 10 April 2026
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 69  (4) , 294-302
Open AccessFuture directions in anesthesia: expanding the role of anesthetic drugs in sedation, analgesia, and recovery
Purpose: Advances in surgical techniques, evolving patient demographics, and the expansion of perioperative care have fundamentally reshaped the objectives of modern anesthesia. Beyond maintaining intraoperative unconsciousness and physiological stability, anesthesia is now increasingly expected to influence postoperative recovery and long-term outcomes. This review examines how recent drug-centered innovations are transforming approaches to anesthesia, analgesia, and postoperative recovery and discusses their implications for the future direction of anesthetic practice.Current concepts: Modern anesthesia is delivered within a highly standardized, technology-driven environment that provides a high level of intraoperative safety. Nevertheless, substantial variability persists in postoperative recovery, neurocognitive outcomes, and complication rates, even among patients undergoing similar surgical procedures. Increasing evidence suggests that these differences are closely associated with the pharmacokinetic and pharmacodynamic properties of anesthetic agents. Accordingly, recent advances have emphasized reversibility, predictability, minimization of residual effects, and recovery-oriented pharmacology. Anesthetic agents with predictable recovery profiles, opioid-sparing multimodal analgesic strategies, and rapid neuromuscular blockade reversal exemplify this transition toward recovery-focused anesthesia management.Discussion and conclusion: Anesthetic strategies are evolving from depth-centered control toward the intentional design of recovery trajectories. Pain management is being restructured to reduce opioid-related adverse effects while promoting functional recovery through multimodal, non-opioid-based approaches. Concurrently, the emergence of reversibility as a core safety principle has reshaped anesthetic decision-making. The selection of anesthetic agents represents a central determinant of postoperative recovery, complications, and patient-centered outcomes. Anesthesia should no longer be viewed solely as a transient intraoperative intervention but rather as a deliberately designed, prognostically influential intervention grounded in strategic, evidence-based pharmacologic decision-making.
- Open Access
- 1 April 2026
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 79  (2) , 213-223
Opioid-based versus opioid-sparing patient-controlled analgesia using ketorolac and nefopam after total knee arthroplasty: a randomized, double-blind, non-inferiority trial
Background: Opioids remain widely used for postoperative pain control after total knee arthroplasty (TKA); however, concerns about adverse effects and dependency drive interest in opioid-sparing alternatives. This study evaluated the efficacy and safety of opioid-sparing patient-controlled analgesia (PCA) after TKA.Methods: In this prospective, randomized, double-blind, non-inferiority study, 98 patients undergoing TKA under spinal anesthesia received either opioid-based PCA (continuous infusion of 1200 μg fentanyl, n = 49) or opioid-sparing PCA (continuous infusion of 150 mg ketorolac tromethamine and 100 mg nefopam hydrochloride, n = 49). Both groups received patient-controlled boluses of 300 μg fentanyl. The primary endpoint was the visual analog scale (VAS) pain score at rest on postoperative day (POD) 1, assessed using a 1.5-point non-inferiority margin. Secondary endpoints included additional analgesics, mobility, postoperative pain at rest and during ambulation, and adverse effects on PODs 1 and 2.Results: The mean VAS score at rest on POD 1 was 5.45 ± 2.48 in the opioid-based PCA group and 5.90 ± 2.31 in the opioid-sparing PCA group. The mean difference was 0.45 points (95% CI, −0.36 to 1.25), within the prespecified non-inferiority margin. Pain scores at each time point were non-inferior in the opioid-sparing group, whereas rescue analgesic requirements were significantly reduced on POD 2 (P = 0.006). Nausea and vomiting on POD 1 were more frequent with opioid-based group (34.7% vs. 12.2%, P = 0.009).Conclusions: Opioid-sparing PCA with ketorolac and nefopam provides non-inferior analgesia to opioid-based PCA, while reducing opioid consumption and drug-related adverse effects after TKA.
- 1 April 2026
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 79  (2) , 213-223
Open AccessOpioid-based versus opioid-sparing patient-controlled analgesia using ketorolac and nefopam after total knee arthroplasty: a randomized, double-blind, non-inferiority trial
Background: Opioids remain widely used for postoperative pain control after total knee arthroplasty (TKA); however, concerns about adverse effects and dependency drive interest in opioid-sparing alternatives. This study evaluated the efficacy and safety of opioid-sparing patient-controlled analgesia (PCA) after TKA.Methods: In this prospective, randomized, double-blind, non-inferiority study, 98 patients undergoing TKA under spinal anesthesia received either opioid-based PCA (continuous infusion of 1200 μg fentanyl, n = 49) or opioid-sparing PCA (continuous infusion of 150 mg ketorolac tromethamine and 100 mg nefopam hydrochloride, n = 49). Both groups received patient-controlled boluses of 300 μg fentanyl. The primary endpoint was the visual analog scale (VAS) pain score at rest on postoperative day (POD) 1, assessed using a 1.5-point non-inferiority margin. Secondary endpoints included additional analgesics, mobility, postoperative pain at rest and during ambulation, and adverse effects on PODs 1 and 2.Results: The mean VAS score at rest on POD 1 was 5.45 ± 2.48 in the opioid-based PCA group and 5.90 ± 2.31 in the opioid-sparing PCA group. The mean difference was 0.45 points (95% CI, −0.36 to 1.25), within the prespecified non-inferiority margin. Pain scores at each time point were non-inferior in the opioid-sparing group, whereas rescue analgesic requirements were significantly reduced on POD 2 (P = 0.006). Nausea and vomiting on POD 1 were more frequent with opioid-based group (34.7% vs. 12.2%, P = 0.009).Conclusions: Opioid-sparing PCA with ketorolac and nefopam provides non-inferior analgesia to opioid-based PCA, while reducing opioid consumption and drug-related adverse effects after TKA.
- 23 March 2026
- Published by BMJ in Regional Anesthesia & Pain Medicine
Crystallization of local anesthetic mixtures with adjuvants and the effect of micropore filtration
Background Regional anesthesia is widely used in pain management to reduce opioid requirements, enable early mobilization and improve postoperative outcomes. However, commonly used combinations of local anesthetics and adjuvants can crystallize under clinical conditions, which generates concerns regarding neurotoxicity and embolization complications. Purpose This study aimed to determine whether microporous filters can effectively eliminate crystals formed by mixing local anesthetics and adjuvant. Method Commonly used local anesthetics (lidocaine, mepivacaine and ropivacaine) and adjuvants (dexamethasone, dexmedetomidine and sodium bicarbonate) were combined and tested. The mixture was passed through 5 µm and 0.2 µm filters, and the presence of crystals before and after filtration at specific time points and volumes was assessed microscopically. Results Lidocaine mixtures showed no detectable crystallization under any condition. In contrast, crystallization occurred in most combinations containing mepivacaine or ropivacaine, with the highest grades observed in ropivacaine–bicarbonate mixtures (grade 5). Filtration reduced crystallization grades by 1–3 points depending on the mixtures, but did not eliminate crystals in most mixtures. Crystals also persisted after longer intervals and with larger filtration volumes. No meaningful difference was observed between the 5 µm and 0.2 µm filters. Conclusion Crystallization can occur in anesthetic–adjuvant mixtures that are commonly used for regional anesthesia. Although filtration reduces these crystals, it does not eliminate crystals, especially those with large volumes or unstable combinations.
- 23 March 2026
- Published by BMJ in Regional Anesthesia & Pain Medicine
Crystallization of local anesthetic mixtures with adjuvants and the effect of micropore filtration
Background Regional anesthesia is widely used in pain management to reduce opioid requirements, enable early mobilization and improve postoperative outcomes. However, commonly used combinations of local anesthetics and adjuvants can crystallize under clinical conditions, which generates concerns regarding neurotoxicity and embolization complications. Purpose This study aimed to determine whether microporous filters can effectively eliminate crystals formed by mixing local anesthetics and adjuvant. Method Commonly used local anesthetics (lidocaine, mepivacaine and ropivacaine) and adjuvants (dexamethasone, dexmedetomidine and sodium bicarbonate) were combined and tested. The mixture was passed through 5 µm and 0.2 µm filters, and the presence of crystals before and after filtration at specific time points and volumes was assessed microscopically. Results Lidocaine mixtures showed no detectable crystallization under any condition. In contrast, crystallization occurred in most combinations containing mepivacaine or ropivacaine, with the highest grades observed in ropivacaine–bicarbonate mixtures (grade 5). Filtration reduced crystallization grades by 1–3 points depending on the mixtures, but did not eliminate crystals in most mixtures. Crystals also persisted after longer intervals and with larger filtration volumes. No meaningful difference was observed between the 5 µm and 0.2 µm filters. Conclusion Crystallization can occur in anesthetic–adjuvant mixtures that are commonly used for regional anesthesia. Although filtration reduces these crystals, it does not eliminate crystals, especially those with large volumes or unstable combinations.
- Open Access
- 31 October 2025
- Published by The Ewha Medical Journal, Ewha Womans University College of Medicine in Ewha Medical Journal
- Vol. 48  (4) , e62
Personalized perioperative pain management: a narrative review
Perioperative pain management has shifted from standardized, procedure-based protocols toward individualized, patient-centered approaches. Inadequate pain control can result in short-term adverse outcomes, including delayed ambulation, prolonged hospitalization, and increased complications, as well as long-term sequelae such as chronic persistent postsurgical pain. Early models of preemptive and preventive analgesia emphasized pain relief primarily through the use of opioids. Growing concern about opioid-related adverse effects established the basis for multimodal and opioid-sparing strategies. Nevertheless, with the onset of the global opioid crisis, heightened awareness of the risks of opioid overuse has fueled interest in opioid-free techniques. However, evidence does not demonstrate that opioid-free methods are superior to opioid-sparing approaches. This underscores the importance of returning to the central goals of enhanced recovery after surgery: early restoration of function and reduction of complications. Within this framework, personalized pain management has emerged as a practical paradigm that tailors interventions to individual characteristics, including comorbidities, psychological status, pain sensitivity, and recovery objectives. This review outlines the rationale, current practices, and future directions of personalized perioperative pain management and proposes a framework for integrating new strategies into clinical care.
- 31 October 2025
- Published by The Ewha Medical Journal, Ewha Womans University College of Medicine in Ewha Medical Journal
- Vol. 48  (4) , e62
Open AccessPersonalized perioperative pain management: a narrative review
Perioperative pain management has shifted from standardized, procedure-based protocols toward individualized, patient-centered approaches. Inadequate pain control can result in short-term adverse outcomes, including delayed ambulation, prolonged hospitalization, and increased complications, as well as long-term sequelae such as chronic persistent postsurgical pain. Early models of preemptive and preventive analgesia emphasized pain relief primarily through the use of opioids. Growing concern about opioid-related adverse effects established the basis for multimodal and opioid-sparing strategies. Nevertheless, with the onset of the global opioid crisis, heightened awareness of the risks of opioid overuse has fueled interest in opioid-free techniques. However, evidence does not demonstrate that opioid-free methods are superior to opioid-sparing approaches. This underscores the importance of returning to the central goals of enhanced recovery after surgery: early restoration of function and reduction of complications. Within this framework, personalized pain management has emerged as a practical paradigm that tailors interventions to individual characteristics, including comorbidities, psychological status, pain sensitivity, and recovery objectives. This review outlines the rationale, current practices, and future directions of personalized perioperative pain management and proposes a framework for integrating new strategies into clinical care.
- Open Access
- 31 October 2025
- Published by The Ewha Medical Journal, Ewha Womans University College of Medicine in Ewha Medical Journal
- Vol. 48  (4) , e61
Two paths, one goal–uniting regional and general anesthesia for optimal surgical care: a narrative review
The integration of regional anesthesia (RA) with general anesthesia (GA) has become a central component of multimodal strategies to improve perioperative pain management. This approach not only enhances analgesic efficacy but also reduces opioid requirements and mitigates opioid-related adverse effects. By targeting peripheral or neuraxial nociceptive pathways, RA attenuates the surgical stress response and decreases central sensitization, complementing the systemic actions of GA. The combined application of RA and GA has shown substantial benefits across a wide range of surgical procedures, including abdominal, thoracic, orthopedic, and pediatric operations. Reported advantages include improved hemodynamic stability, enhanced pulmonary function, earlier ambulation, faster gastrointestinal recovery, and greater patient satisfaction. Moreover, recent evidence indicates a positive association between effective postoperative pain control and long-term outcomes, such as reduced incidence of persistent postsurgical pain, better functional independence, and even improved immune function and survival following cancer surgery. The development of sustained-release local anesthetic delivery systems, which provide localized and prolonged analgesia, further extends the benefits of RA-GA integration into the postoperative period. This review summarizes the mechanistic rationale, clinical applications, and future directions of RA-GA combinations in modern surgical care, with special emphasis on their role in enhanced recovery after surgery protocols.
- 31 October 2025
- Published by The Ewha Medical Journal, Ewha Womans University College of Medicine in Ewha Medical Journal
- Vol. 48  (4) , e61
Open AccessTwo paths, one goal–uniting regional and general anesthesia for optimal surgical care: a narrative review
The integration of regional anesthesia (RA) with general anesthesia (GA) has become a central component of multimodal strategies to improve perioperative pain management. This approach not only enhances analgesic efficacy but also reduces opioid requirements and mitigates opioid-related adverse effects. By targeting peripheral or neuraxial nociceptive pathways, RA attenuates the surgical stress response and decreases central sensitization, complementing the systemic actions of GA. The combined application of RA and GA has shown substantial benefits across a wide range of surgical procedures, including abdominal, thoracic, orthopedic, and pediatric operations. Reported advantages include improved hemodynamic stability, enhanced pulmonary function, earlier ambulation, faster gastrointestinal recovery, and greater patient satisfaction. Moreover, recent evidence indicates a positive association between effective postoperative pain control and long-term outcomes, such as reduced incidence of persistent postsurgical pain, better functional independence, and even improved immune function and survival following cancer surgery. The development of sustained-release local anesthetic delivery systems, which provide localized and prolonged analgesia, further extends the benefits of RA-GA integration into the postoperative period. This review summarizes the mechanistic rationale, clinical applications, and future directions of RA-GA combinations in modern surgical care, with special emphasis on their role in enhanced recovery after surgery protocols.
- Open Access
- 31 July 2025
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 20  (3) , 187-188
Beyond numbers: the beginning of a new possibility
- 31 July 2025
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 20  (3) , 187-188
Open AccessBeyond numbers: the beginning of a new possibility
- Open Access
- 26 June 2025
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 38  (3) , 341-354
Pain assessment using the Analgesia Nociception Index in patients undergoing sedation: a systematic review and meta-analysis
Min Kyoung Kim, Oh Haeng Lee, Geun Joo Choi, and Hyun Kang. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25105
- 26 June 2025
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 38  (3) , 341-354
Open AccessPain assessment using the Analgesia Nociception Index in patients undergoing sedation: a systematic review and meta-analysis
Min Kyoung Kim, Oh Haeng Lee, Geun Joo Choi, and Hyun Kang. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25105
- Open Access
- 10 January 2025
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 68  (1) , 20-28
Regional anesthesia for rapid recovery after orthopedic surgery
Background: Orthopedic surgery is becoming increasingly common, particularly among older adults, due to population aging and the rising incidence of degenerative conditions. Older patients frequently have multiple comorbidities, which elevate the risk of surgical complications. Effective pain management is crucial in facilitating recovery and reducing the likelihood of postoperative complications. This review examines the role of regional anesthesia in optimizing recovery outcomes for orthopedic patients.Current Concepts: Regional anesthesia significantly reduces opioid consumption, which in turn mitigates side effects such as nausea, vomiting, respiratory depression, and urinary retention. It also promotes early mobilization, which is crucial for functional recovery, and helps prevent complications such as deep vein thrombosis and muscle atrophy. Advanced techniques like local infiltration analgesia and motor-sparing blocks offer effective pain relief while preserving muscle strength. This not only facilitates faster rehabilitation but also reduces the length of hospital stays. These advantages underscore the importance of regional anesthesia in improving surgical outcomes and expediting recovery.Discussion and Conclusion: Regional anesthesia is crucial in improving recovery after orthopedic surgery by providing effective pain management, facilitating early mobilization, and minimizing complications. It is essential to customize the anesthetic approach based on the specific surgical procedure and the patient’s overall health to achieve optimal outcomes.
- 10 January 2025
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 68  (1) , 20-28
Open AccessRegional anesthesia for rapid recovery after orthopedic surgery
Background: Orthopedic surgery is becoming increasingly common, particularly among older adults, due to population aging and the rising incidence of degenerative conditions. Older patients frequently have multiple comorbidities, which elevate the risk of surgical complications. Effective pain management is crucial in facilitating recovery and reducing the likelihood of postoperative complications. This review examines the role of regional anesthesia in optimizing recovery outcomes for orthopedic patients.Current Concepts: Regional anesthesia significantly reduces opioid consumption, which in turn mitigates side effects such as nausea, vomiting, respiratory depression, and urinary retention. It also promotes early mobilization, which is crucial for functional recovery, and helps prevent complications such as deep vein thrombosis and muscle atrophy. Advanced techniques like local infiltration analgesia and motor-sparing blocks offer effective pain relief while preserving muscle strength. This not only facilitates faster rehabilitation but also reduces the length of hospital stays. These advantages underscore the importance of regional anesthesia in improving surgical outcomes and expediting recovery.Discussion and Conclusion: Regional anesthesia is crucial in improving recovery after orthopedic surgery by providing effective pain management, facilitating early mobilization, and minimizing complications. It is essential to customize the anesthetic approach based on the specific surgical procedure and the patient’s overall health to achieve optimal outcomes.